EP3675863A1 — Pharmaceutical compositions comprising sepiapterin and uses thereof
Assigned to PTC Therapeutics MP Inc · Expires 2020-07-08 · 6y expired
What this patent protects
The present invention relates to pharmaceutical compositions comprising sepiapterin, or a pharmaceutically acceptable salt and / or co-crystal thereof, and methods for the treatment of disorders related to tetrahydrobiopterin (e.g., tetrahydrobiopterin deficiency or phenylketonur…
USPTO Abstract
The present invention relates to pharmaceutical compositions comprising sepiapterin, or a pharmaceutically acceptable salt and / or co-crystal thereof, and methods for the treatment of disorders related to tetrahydrobiopterin (e.g., tetrahydrobiopterin deficiency or phenylketonuria) using such compositions.
Drugs covered by this patent
- Sephience (SEPIAPTERIN) · Ptc Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.